alreadi
known
topic
respiratori
syncyti
viru
rsv
rhinoviru
rv
induc
bronchiol
associ
increas
risk
asthma
articl
add
knowledg
compar
children
rsvinduc
bronchiol
children
rvae
rvceinduc
bronchiol
start
asthma
control
medic
earlier
like
use
year
later
risk
especi
high
among
patient
rvc
atop
dermat
fever
studi
impact
current
manag
guidelin
secondari
prevent
strategi
target
rhinovirus
especi
rvc
might
help
prevent
childhood
asthma
background
respiratori
syncyti
viru
rsv
rhinoviru
rv
induc
bronchiol
associ
increas
risk
asthma
detail
inform
need
viru
type
object
studi
whether
rsv
rv
type
differenti
associ
futur
use
asthma
control
medic
method
consecut
winter
season
enrol
children
hospit
bronchiol
age
less
month
prospect
followup
studi
finland
viru
detect
perform
realtim
revers
transcript
pcr
nasal
wash
sampl
four
year
later
examin
current
use
asthma
control
medic
result
total
children
complet
followup
studi
entri
median
age
month
rsv
rv
rsv
rv
nonrsvrv
etiolog
children
rva
adjust
hazard
ratio
p
rvc
adjust
hazard
ratio
p
nonrsvrv
adjust
hazard
ratio
p
bronchiol
start
asthma
control
medic
earlier
children
rsv
bronchiol
four
year
later
patient
use
asthma
control
medic
rva
adjust
odd
ratio
p
rvc
adjust
odd
ratio
p
etiolog
associ
current
use
asthma
medic
highest
risk
found
among
patient
rvc
atop
dermat
fever
adjust
odd
ratio
p
conclus
sever
bronchiol
caus
rva
rvc
associ
earlier
initi
prolong
use
asthma
control
medic
risk
especi
high
bronchiol
associ
rvc
atop
dermat
fever
bronchiol
infect
small
airway
caus
breath
difficulti
young
children
one
lead
reason
hospit
among
infant
without
underli
ill
sever
bronchiol
also
consid
risk
factor
futur
asthma
respiratori
syncyti
viru
rsv
frequent
caus
bronchiol
virus
especi
rhinoviru
rv
also
detect
followup
studi
rvinduc
bronchiolitisearli
wheez
ill
highli
associ
abbrevi
use
ahradjust
hazard
ratio
aoradjust
odd
ratio
hrhazard
ratio
orodd
ratio
rsvrespiratori
syncyti
viru
rvrhinoviru
develop
asthma
whether
rv
infect
immunolog
respons
child
primarili
enhanc
develop
still
partli
unknown
furthermor
unclear
whether
rv
type
involv
bronchiol
differ
risk
associ
later
develop
asthma
rv
caus
bronchiol
wheez
episod
asthma
exacerb
children
rv
type
classifi
speci
rva
rvb
rvc
rva
rvc
caus
sever
respiratori
ill
rvb
associ
wheez
earli
childhood
well
exacerb
asthma
cadherinrel
famili
member
receptor
rvc
atopi
shown
risk
factor
develop
earlyonset
asthma
cadherinrel
famili
member
mediat
rvc
bind
replic
airway
epithelia
polymorph
gene
encod
protein
link
increas
suscept
asthma
aim
studi
whether
rsv
rv
type
differ
associ
use
longterm
asthma
control
medic
year
sever
bronchiol
infanc
studi
hypothesi
rva
rvc
etiolog
sever
bronchiol
associ
increas
need
longterm
asthma
control
medic
studi
subject
consist
particip
multicent
airway
research
collabor
finland
studi
prospect
multicent
cohort
studi
emerg
medicin
network
emnet
boston
mass
children
recruit
pediatr
ward
intens
care
unit
kuopio
tamper
turku
univers
hospit
finland
winter
season
novemb
march
children
hospit
bronchiol
younger
month
admiss
diagnosi
bronchiol
clinic
made
accord
american
academi
pediatr
guidelin
includ
children
acut
respiratori
ill
combin
rhiniti
cough
tachypnea
wheez
crackl
andor
retract
initi
exclus
made
basi
histori
wheez
use
asthma
medic
hospit
addit
identifi
subgroup
infant
younger
month
histori
wheez
strict
bronchiol
criteria
exclus
criteria
previou
enrol
transfer
particip
hospit
hour
origin
admiss
time
children
hospit
defin
sever
bronchiol
institut
ethic
board
turku
univers
hospit
approv
studi
institut
ethic
board
particip
hospit
confirm
approv
parent
guardian
gave
written
inform
consent
studi
hospit
guardian
interview
use
structur
questionnair
includ
demograph
environment
baselin
medic
data
also
data
sign
symptom
manag
current
infect
collect
four
year
hospit
studi
questionnair
modifi
intern
studi
asthma
allergi
childhood
questionnair
sent
particip
questionnair
consist
inquiri
respiratori
symptom
need
prescript
use
asthma
medic
followup
period
index
hospit
parent
respond
within
month
particip
contact
telephon
interview
regular
use
inhal
corticosteroid
leukotrien
receptor
antagonist
ever
report
patient
file
ie
hospit
record
inquiri
sent
privat
sector
pediatrician
report
medic
encount
review
exact
prescript
time
medic
nasopharyng
wash
sampl
collect
studi
entri
use
standard
protocol
collect
equip
medlin
industri
mundelein
ill
use
hospit
sampl
collect
within
hour
child
arriv
ward
intens
care
unit
instil
ml
normal
salin
nari
suction
thereaft
sampl
immedi
refriger
store
c
within
hour
analys
viral
detect
perform
use
singleplex
duplex
realtim
pcr
realtim
revers
transcript
pcr
use
detect
rna
respiratori
virus
rsv
type
b
rhinoviru
type
b
c
parainfluenza
viru
type
influenza
viru
type
b
novel
human
metapneumoviru
coronavirus
enterovirus
realtim
pcr
detect
dna
pathogen
adenoviru
mycoplasma
pneumonia
bordetella
pertussi
detail
primer
probe
describ
earlier
pcr
assay
test
duplic
sampl
incongru
valu
well
posit
retest
analys
children
divid
group
basi
virolog
test
rsv
includ
coinfect
virus
rv
rv
includ
coinfect
virus
rsv
nonrsvrv
includ
coinfect
virus
rsv
rv
time
initi
longterm
asthma
control
inhal
corticosteroid
leukotrien
receptor
antagonist
medic
defin
time
discharg
index
hospit
prescript
least
period
asthma
control
medic
children
report
use
asthma
control
medic
index
hospit
exclud
analys
current
use
longterm
asthma
control
medic
defin
prescript
regular
asthma
control
medic
within
previou
month
use
prescript
asthma
control
medic
report
parent
interview
patient
medic
file
review
exact
begin
medic
use
atop
dermat
defin
parentreport
atop
dermat
diagnos
physician
ige
immunolog
test
done
fever
defin
temperatur
higher
c
f
sever
bronchiol
episod
case
miss
data
initi
time
medic
confound
use
multivari
analys
child
question
exclud
particular
analysi
unadjust
analys
categor
data
done
use
pearson
c
test
continu
data
use
kruskalw
test
multivari
analys
done
use
binari
logist
cox
regress
result
present
odd
ratio
or
hazard
ratio
hr
respect
confid
interv
potenti
confound
factor
first
test
unadjust
analys
nonvir
factor
select
backward
stepwis
method
variabl
p
less
includ
final
adjust
model
test
variabl
age
index
hospit
vs
month
sex
parent
histori
asthma
gestat
week
birth
vs
week
comorbid
medic
disord
histori
wheez
histori
atop
dermat
sibl
exposur
smoke
pregnanc
earli
childhood
breastfeed
length
index
hospit
greater
equal
day
use
system
corticosteroid
index
hospit
ye
vs
studi
center
turku
tamper
vs
kuopio
analys
conduct
ibm
spss
statist
window
version
ibm
corp
armonk
ny
among
infant
follow
year
hospit
return
questionnair
underw
telephon
interview
figur
howev
child
discord
data
thu
taken
togeth
children
suffici
followup
data
includ
cohort
studi
time
hospit
patient
rsv
rv
rsv
rv
neg
virus
nonrsvrv
tabl
patient
rvc
rva
rvb
rvb
rvc
tabl
median
age
studi
entri
month
male
parent
asthma
born
preterm
comorbid
medic
disord
histori
wheez
histori
atop
dermat
tabl
baselin
characterist
similar
dropout
group
except
includ
less
male
children
earli
childhood
smoke
exposur
children
compar
relat
viru
type
tabl
ii
betweengroup
differ
seen
children
rsv
younger
less
comorbid
medic
disord
need
longer
hospit
often
intens
care
unit
care
wherea
histori
wheez
atop
dermat
use
system
corticosteroid
initi
hospit
common
among
children
patient
characterist
children
rva
rvc
similar
patient
data
adequ
analys
initi
time
medic
report
prescript
asthma
control
medic
within
month
hospit
tabl
iii
asthma
control
medic
start
mean
month
hospit
patient
rv
month
patient
nonrsvrv
month
patient
rsv
bronchiol
see
figur
articl
onlin
repositori
wwwjaciinpracticeorg
patient
rv
adjust
p
nonrsvrv
adjust
p
bronchiol
start
asthma
control
medic
significantli
earlier
rsv
bronchiol
tabl
iii
figur
rv
type
analyz
separ
asthma
control
medic
start
significantli
earlier
rvc
month
adjust
p
rva
bronchiol
month
adjust
p
tabl
iii
figur
children
detail
data
medic
use
followup
children
use
inhal
corticosteroid
furthermor
children
rsv
children
rv
children
nonrsv
rv
bronchiol
use
leukotrien
receptor
antagonist
point
followup
p
differ
p
found
use
leukotrien
receptor
antagonist
rva
children
rvc
children
four
year
bronchiol
patient
rv
patient
nonrsvrv
patient
rsv
bronchiol
use
asthma
control
medic
past
month
tabl
iv
patient
rv
infect
like
use
asthma
control
medic
compar
rsv
infect
adjust
p
tabl
iv
rv
type
compar
separ
rva
adjust
p
rvc
adjust
p
associ
current
use
asthma
control
medic
tabl
iv
figur
unadjust
analys
patient
neg
virus
use
asthma
control
medic
patient
rsv
p
differ
longer
signific
adjust
p
tabl
iv
figur
also
analyz
nonvir
risk
factor
studi
entri
initi
current
use
asthma
control
medic
see
tabl
articl
onlin
repositori
wwwjaciinpracticeorg
histori
wheez
adjust
hr
ahr
p
atop
dermat
ahr
p
use
system
corticosteroid
index
hospit
ahr
p
independ
risk
factor
multivari
analysi
initi
asthma
control
medic
addit
bronchiol
caus
rva
ahr
p
rvc
ahr
p
nonrsvrv
ahr
p
wherea
length
hospit
stay
day
ahr
p
tabl
respect
current
use
asthma
medic
year
bronchiol
histori
atop
dermat
adjust
aor
p
addit
bronchiol
caus
rva
aor
p
rvc
aor
p
signific
risk
factor
tabl
children
rvc
infect
analyz
separ
histori
atop
dermat
fever
time
hospit
like
use
asthma
medic
year
bronchiol
aor
p
compar
children
histori
atop
dermat
aor
p
fever
aor
p
neither
figur
characterist
children
bronchiol
defin
strict
criteria
age
month
first
wheez
present
tabl
articl
onlin
repositori
www
jaciinpracticeorg
bronchiol
induc
rsv
rvc
infect
test
posit
rva
tabl
rvc
adjust
p
nonrsvrv
adjust
p
bronchiol
associ
earlier
prescript
asthma
control
medic
compar
rsv
bronchiol
see
tabl
articl
onlin
repositori
wwwjaciinpracticeorg
rvc
bronchiol
also
increas
use
asthma
medic
year
later
hospit
compar
rsv
adjust
p
see
tabl
articl
onlin
repositori
wwwjaciinpracticeorg
studi
clinic
interest
find
first
among
children
hospit
bronchiol
age
year
bronchiol
caus
rva
rvc
associ
earlier
initi
asthma
control
medic
second
year
rva
rvc
bronchiol
patient
still
use
asthma
control
medic
compar
patient
rsv
patient
nonrsvrv
bronchiol
third
patient
rvc
bronchiol
atop
dermat
fever
highest
risk
develop
asthma
fourth
bronchiol
caus
rvc
also
associ
earlier
initi
asthma
control
medic
children
initi
wheez
episod
first
year
life
sever
factor
contribut
linkag
rvinduc
wheez
infanc
risk
childhood
asthma
inflammatori
respons
caus
differ
rv
might
damag
airway
although
rsv
could
caus
even
structur
damag
airway
epithelium
rv
howev
chang
epitheli
barrier
function
even
infect
increas
risk
sever
rv
bronchiol
host
factor
atopi
low
ifn
respons
could
addit
effect
addit
risk
gene
cadherinrel
famili
member
encod
receptor
rvc
predispos
children
sever
rvc
infect
develop
asthma
final
rv
infect
inhibit
ifn
respons
potenti
h
inflamm
product
cytokin
promot
airway
obstruct
wheez
atop
characterist
seen
risk
factor
rsvinduc
wheez
asthma
link
young
age
low
lung
function
indic
time
rsv
infect
may
import
futur
develop
respiratori
ill
similarli
genet
factor
modifi
risk
rsv
bronchiol
develop
asthma
find
strong
associ
rvae
rvceinduc
bronchiol
use
asthma
control
medic
year
later
consist
previou
rv
studi
recent
metaanalysi
includ
origin
articl
associ
rvinduc
wheez
later
develop
asthma
confirm
previou
report
link
rva
rvc
recurr
wheez
alreadi
evid
followup
interestingli
studi
other
need
longterm
asthma
control
medic
typic
develop
within
year
rvinduc
bronchiol
earlylif
rv
wheez
ill
aeroallergen
sensit
increas
risk
asthma
highrisk
birth
cohort
persist
asthma
age
year
shown
strongli
addit
associ
rv
wheez
ill
aeroallergen
sensit
earli
life
accord
show
histori
wheez
atop
dermat
rvae
rvceinduc
bronchiol
independ
associ
initi
current
use
asthma
control
medic
year
later
data
studi
suggest
atop
airway
like
develop
obstruct
chang
rvrelat
wheez
also
sever
febril
viral
respiratori
infect
infanc
earli
atopi
known
risk
factor
persist
wheez
asthma
similarli
studi
occurr
rvc
bronchiol
atop
dermat
fever
togeth
especi
import
marker
risk
wheez
asthma
later
childhood
bronchiol
defin
differ
unit
state
europ
also
analyz
data
use
strict
european
criteria
bronchiol
exampl
age
less
month
first
wheez
episod
use
strict
criteria
bronchiol
rvc
bronchiol
first
year
life
strongli
associ
increas
use
asthma
medic
year
later
wherea
rva
bronchiol
rare
age
group
agreement
previou
report
recurr
wheez
within
followup
strength
studi
prospect
design
longitudin
followup
high
followup
rate
reallif
studi
hospit
patient
bronchiol
younger
year
includ
also
conduct
analys
separ
children
bronchiol
strict
criteria
make
popul
uniform
consid
possibl
effect
previou
wheez
ill
addit
differ
virus
evalu
time
bronchiol
later
use
asthma
medic
care
character
use
registri
data
addit
parent
report
howev
specif
test
confirm
allerg
sensit
perform
one
limit
cohort
includ
patient
sever
bronchiol
case
hospit
age
year
role
viral
infect
may
differ
children
milder
form
bronchiol
challeng
prevent
develop
asthma
achiev
reevalu
diagnosi
bronchiol
gener
consid
uniform
entiti
howev
data
suggest
bronchiol
instead
diseas
subgroup
differ
risk
factor
genet
pathogenet
etiolog
lead
dissimilar
respons
treatment
distinct
prognosi
previou
trial
shown
system
corticosteroid
first
rvinduc
wheez
episod
reduc
recurr
need
asthma
control
medic
although
trial
rv
subtyp
result
confirm
trial
test
viral
etiolog
bronchiol
could
recommend
forthcom
treatment
guidelin
better
estim
futur
risk
develop
asthma
studi
also
suggest
prevent
strategi
target
either
rva
especi
rvc
inflammatori
respons
associ
virus
might
help
prevent
least
type
childhood
asthma
